High Dose UVA-1 Phototherapy for Morphea.
- Author:
Kee Suck SUH
1
;
Jin Woo LEE
;
Hyo Jin ROH
;
Soo Young CHOI
;
Ki Seung DOH
;
Sang Tae KIM
Author Information
1. Department of Dermatology, Kosin University College of Medicine, Busan, Korea. ksderm98@unitel.co.kr
- Publication Type:Case Report
- Keywords:
Collagenase I;
High dose UVA-1;
Morphea
- MeSH:
Antimalarials;
Collagenases;
Connective Tissue;
Cyclosporine;
Female;
Humans;
Penicillamine;
Phototherapy*;
Scleroderma, Localized*
- From:Korean Journal of Dermatology
2007;45(1):76-78
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Morphea is a rare, sclerotic connective tissue disorder and is thought to be caused by a decreased collagenase activity. Numerous treatment modalities have been tried, such as infiltration with glucocorticosteroid, D-penicillamine, antimalarial agents and cyclosporine. However, all have shown only limited success. We report a case of a 21 year- old female with localized scleroderma, who showed a marked improvement after localized therapy with high dose UVA-1.
